Company news
Aurora Cannabis Inc. (TSX:ACB) news
Every Aurora Cannabis Inc. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
August 24, 2026
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Ex...
August 19, 2026
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, ...
August 19, 2026
Curaleaf Announces Intention to Launch Take-Over Bid for Aurora Cannabis to Solidify its Position as the Global Cannabis Industry Leader
August 11, 2026
Aurora, a Global Leader in Medical Cannabis, Announces Results of 2026 Annual General Meeting
August 10, 2026
Aurora Cannabis : Management Discussion & AnalysisPDF (MDA 202660 Q1 2027 August 4 Final)
August 5, 2026
Aurora Cannabis Announces Fiscal 2027 First Quarter Results
August 5, 2026
Aurora Announces Second Quarter 2026 Results
July 29, 2026
Aurora Receives Support from Leading Independent Proxy Adviser Institutional Shareholder Services Inc. for the 2026 Annual General Meetin...
July 27, 2026
Safari Flower Company, a Wholly Owned Subsidiary of Aurora Cannabis, Receives EU-GMP Certification at Niagara Facility
July 23, 2026
Aurora Cannabis to Host First Quarter 2027 Investor Conference Call
July 22, 2026
Aurora Named to TIME Canada's Best Companies 2026 List
July 9, 2026
Aurora Cannabis Announces Full Year and Fiscal 2026 Fourth Quarter Results with Record Annual Revenue and Adjusted EBITDA¹
June 11, 2026
Aurora Deepens its Impact for Veterans Across Canada
June 2, 2026
Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
May 28, 2026
Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
May 14, 2026
Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
April 28, 2026
Canadian Investment Regulatory Organization Trade Resumption - ACB
April 22, 2026
Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capa...
April 15, 2026
Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year
March 30, 2026
Aurora to Participate in the TD Cowen 46th Annual Health Care Conference
February 17, 2026
Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis
February 12, 2026
Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand
February 11, 2026
Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program
February 4, 2026
Aurora Cannabis Announces Fiscal 2026 Third Quarter Results
February 4, 2026
Aurora Launches New European Websites, Showcasing Science-Backed Cannabis Leadership
February 3, 2026
Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call
January 21, 2026
Aurora Secures EU Community Plant Variety Rights for Two Proprietary Cannabis Varieties
January 20, 2026
Aurora Achieves Significant Progress in Disease Resistance Research
January 14, 2026
Aurora Launches Daily Special™ in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients
December 18, 2025
Aurora Launches Daily Special(TM) in Germany, Delivering High-Quality, Affordable Medical Cannabis to Patients
December 18, 2025
Aurora Expands Leading Portfolio of High-Potency Medical Flower Products in Poland
December 11, 2025
Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand
December 8, 2025
Aurora Announces Distribution Partnership with Leafio Australia
December 2, 2025
Rubicon Organics Announces Appointment of Glen Ibbott as CFO
November 12, 2025
Aurora Cannabis Announces Fiscal 2026 Second Quarter Results
November 5, 2025
Aurora Cannabis to Host Second Quarter 2026 Investor Conference Call
October 22, 2025
Aurora Announces Investment into German Manufacturing Facility
September 18, 2025
Aurora and Copeia Launch English Version of Physician Experience Platform (PEP), Expanding Access to Peer-Reviewed Medical Cannabis Case ...
September 9, 2025
Aurora, a Leading Global Medical Cannabis Company, Attends the H.C. Wainwright 27th Annual Global Investment Conference
September 8, 2025
Aurora Ignites Global Expansion with Whistler Cannabis Co. Brand Debut in Australia
August 12, 2025
Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting
August 8, 2025
Aurora to Participate in Canaccord Genuity 45th Annual Growth Conference
August 7, 2025
Aurora Cannabis Announces Fiscal 2026 First Quarter Results
August 6, 2025
Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2025 Annual General and Special Meeting...
July 30, 2025
SIMPLY SOLVENTLESS ANNOUNCES APPOINTMENT OF ANANTH KRISHNAN TO THE POSITION OF CHIEF FINANCIAL OFFICER
July 24, 2025
Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
July 23, 2025
Aurora Continues Deep Commitment to Veterans Through Strains for Heroes Initiative
July 16, 2025
Aurora Completes First-Ever EU-GMP Certification for the Company's Dedicated Distribution Centre
July 14, 2025
Aurora Cannabis Inc. Announces Filing and Mailing of the Management Information Circular in Connection with the Annual General and Specia...
July 9, 2025